During the past decade, Terveystalo Ruoholahti conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Terveystalo Ruoholahti" #1 sponsor was "H. Lundbeck A/S" with 3 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Biogen" with 1 trials sponsored and "Chordate Medical" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Terveystalo Ruoholahti" #1 collaborator was "FGK Clinical Research GmbH" with 1 trials as a collaborator, "Novartis" with 1 trials as a collaborator and "Vinnova (Swedish Governmental Agency for Innovation Systems)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Terveystalo Ruoholahti" are "Alzheimer Disease" (2 trials), "Alzheimer's Disease" (1 trials), "Chronic Cluster Headache" (1 trials), "Chronic Migraine" (1 trials) and "Cluster Headache, Episodic" (1 trials). Many other conditions were trialed in "Terveystalo Ruoholahti" in a lesser frequency.

Most popular intervention types in "Terveystalo Ruoholahti" are "Drug" (7 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Eptinezumab" (3 trials), "Placebo" (3 trials), "Gantenerumab" (2 trials), "AMG334" (1 trials) and "Aducanumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Terveystalo Ruoholahti" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Terveystalo Ruoholahti". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Terveystalo Ruoholahti, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Terveystalo Ruoholahti, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".